⌕
Healthequity · HQY · Nasdaq
Tenet 63 · Solid
Compare
$101.84−2.62%At closeTenet 63 · Solid
$101.84−2.74 (−2.62%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Healthequity (HQY) Earnings Forecast

Analysts expect Healthequity (HQY) to earn $4.72 a share in FY27, the average of 10 estimates as of Nov 16, 2026.

Sources Analyst estimates EstimatesConsensus as of How we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

FY27 consensus EPS
$4.72
10 analysts
FY28 consensus EPS
$5.52
10 analysts · low $5.30, high $5.90
EPS revisions, 31 days
0.0%
$4.72 to $4.72
Disagreement, FY27
1.3%
high to low, $4.70 to $4.76

Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.

Consensus as of Nov 16, 2026 · we check it nightly

Analysts expect Healthequity to earn $6.06 a share in FY29, growing about 13% a year; 4 analysts publish an estimate for FY29.

Forward P/E · FY27E
22.1×
$104.58 (as of close, Nov 16, 2026) ÷ $4.72 consensus EPS
Coverage · FY27
10 · 11
EPS estimates · revenue estimates

Are estimates going up or down lately?

The FY27 EPS consensus is $4.72, up 0.1% in 90 days. Every figure compares one fiscal period at both ends.

EPS consensus, change over the last 90 days. One step per nightly change.

−0.2%+0.6%+1.5%FY28 +1.3%FY27 +0.1%Aug 18Nov 16
EPS30 days90 daysshown aboveSince Jul 6
FY2710 analysts◆ 0.0%$4.72 to $4.72▲ +0.1%$4.72 to $4.72▲ +0.1%$4.72 to $4.72
FY2810 analysts▲ +0.3%$5.50 to $5.52▲ +1.3%$5.45 to $5.52▲ +0.9%$5.47 to $5.52
Oct '269 analysts▲ +0.1%$1.15 to $1.15▼ −0.1%$1.15 to $1.15▼ −0.1%$1.15 to $1.15
Jan '279 analysts◆ 0.0%$1.10 to $1.1063 of 90 days0.0% so far◆ 0.0%$1.10 to $1.10

Contributors at both ends of the window: FY27 10 and 10. A change in the average can come from a new contributor as much as from a changed mind, so both counts stay in view.

Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.

If the Street is right, what does that imply for the share price?

Price as of close, Nov 16, 2026 · consensus as of Nov 16, 2026

At 37.2 times earnings, which is what Healthequity trades at today, the FY28 consensus of $5.52 works out to $205 a share.

Consensus EPS · FY28
$5.52
10 analysts · low $5.30, high $5.90 · thin coverage
Multiple · today's trailing P/E
37.2×
$104.58 (as of close, Nov 16, 2026) ÷ $2.81, the last four reported quarters, including EPS computed by Tenet
×
Receipt · HQY · FY28Nov 16, 2026
Implied, a share
$205

Range on the low and high estimate: $197 to $219.

$197 low$219 high
5.52 × 37.2, to the dollar
Drag the multipleShaded: where Healthequity's P/E sat at each fiscal year end, FY15 to FY26. Each dot is one year.
31×35×40×45×50×55×60×
today 37.2×$205 a share

Each point on the line is a multiple, and the flag is the price it implies for FY28. Past multiples are context, not a guide to future ones.

This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.

You are paying 22.1 times the FY27 consensus for earnings the Street expects to grow about 13% a year to FY29. That is 1.7 times the growth rate.Show today's multiple against its own recordHide the multiple record
Trailing P/E at each fiscal year end, FY15 to FY26 · over 9 fiscal years, with 1 year of near-zero earnings left out. The mark is the median of the last 9.
37.2× today
34.8× low118.0× high
101.4× median
Forward 22.1× is a different measure, so it is not placed on a trailing record. Today's mark is the trailing 37.2×, on the same basis as every year behind it.

How much do analysts disagree?

For FY29, estimates run from $5.46 to $6.51 around an average of $6.06, drawn by 4 analysts.

FY27E10 analysts
$4.70 to $4.76 · 1.3%
FY28E10 analysts
$5.30 to $5.90 · 11.0%
FY29E4 analysts
$5.46 to $6.51 · 17.3%

The dashed line is FY26 filed $2.46, on the GAAP basis.

A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average.

Is next quarter a high bar or an easy one?

Analysts expect Healthequity to earn $1.15 a share in the October quarter, the average of 9 estimates. Results are expected by Dec 7, 2026.

$0.59
$1.15high $1.18
low $1.12
+95.2%crosses bases
Oct 2025 quarterfiled · GAAPOct 2026 quarterconsensus · Street basis · 9 analysts
Expected report
Dec 7, 2026
Expected by Dec 7. An estimate, not a date the company has set. Companies move it.
Revenue expected · October quarter
$347.2M
9 analysts, 345.4 to 350.0 in $M · 322.2 in the same quarter a year ago

The step from a filed quarter to a consensus crosses bases: the filed figure is the company's own GAAP number and the consensus is on the Street's basis. It is printed with both bases named, not as growth. For the January quarter, analysts expect $1.10 a share.

Does Healthequity usually beat or miss?

We have not been able to check a quarter yet. Our record of estimates for Healthequity begins on Jul 6, 2026, and a quarter can be checked only when we hold an estimate for it from before the company reported. The next report is expected by Dec 7, 2026.

We started recording estimates on Jul 6, 2026, so quarters that reported before that date cannot be checked.

Before our record
Oct '23
Jan '24
Our record, one quarter per report
Apr '24left out · adjusted
Jul '24left out · adjusted
Oct '24left out · adjusted
Jan '25left out · adjusted
Apr '25left out · adjusted
Jul '25left out · adjusted
Oct '25left out · adjusted
Jan '26left out · adjusted
Apr '26left out · adjusted
Jul '26left out · adjusted
reportsDec 7
Oct '26
Jan '27
Checked so far
None yet
one more every report
Beat expectations
Nothing to count
the first check lands after the next report
Share price reaction
Not held
there is no checked quarter to measure a reaction for
Typical gap vs estimate
Not yet
shown once 4 quarters are checked

Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for Healthequity on Jul 6, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact.

The Street expects sales to grow 7.6% in FY28 and EPS 16.8%. Sales are part of it: the net margin moves from 29.2% to 32.1%, and the implied share count from about 87.7M to 88.8M, so these numbers assume no buyback.Show the decomposition and the margin ladderHide the decomposition
FY28 EPS growth, in points
Revenue growth+7.6
Net margin change+10.7
Share count change−1.5
EPS growth+16.8
Legs are rounded to a tenth of a point and the largest remainder carries the difference, so they add to the total. Implied shares = consensus net income ÷ consensus EPS, a direction rather than a decimal.
10 analysts publish an EPS estimate for FY27 and 11 publish revenue. Coverage thins with distance: 4 EPS estimates for FY29. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by year and over timeHide the coverage chart
Analysts by fiscal year · outlined revenue, filled EPS. Amber marks a panel of fewer than 15.
1110
FY27E
1110
FY28E
54
FY29E
The FY27 panel held 11 analysts when our record of it began on Jul 6, 2026 and holds 10 tonight.

The full consensus, year by year

Consensus as of Nov 16, 2026 · filed figures as reported
Revenue · $Bfiled · consensus average · band = low to high
0.81.21.7historyStreet forecastFY23FY26FY29E

Coverage thins with distance: 11 revenue estimates for FY27, 5 for FY29.

Diluted EPS · $filed · consensus average · band = low to high
−0.723.036.78historyStreet forecastFY23FY26FY29E

Out-year bands widen as fewer analysts publish: 10 EPS estimates for FY27, 4 for FY29.

Fiscal yearRevenue $BYoYEPS $YoYEBITDA $BNet inc. $BShares BAnalysts rev · EPSFwd P/E
FY26Filed1.3—2.46————as filed37.2×
FY27E1.41.4 to 1.4▲7.9%a4.724.70 to 4.76▲92.1%a0.80.40.0911 · 1022.1×
FY28E1.51.5 to 1.6▲7.6%5.525.30 to 5.90▲16.8%0.90.50.0911 · 1019.0×
FY29E1.61.6 to 1.6n/cb6.065.46 to 6.51n/cb0.80.50.085 · 417.3×

Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over the last four reported quarters, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.

These are consensus estimates: what analysts expect the business to earn, not where they think the stock trades. Coverage thins and the low to high band widens in the out-years. Context, not advice.

Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 10 EPS estimates for FY27, 11 for revenue. Not investment advice.

What do analysts expect Healthequity to earn in FY27?

Analysts expect Healthequity to earn $4.72 a share in FY27, the average of 10 estimates as of Nov 16, 2026.

What is Healthequity's earnings forecast for FY28?

The FY28 consensus for Healthequity is $5.52 a share from 10 analysts, with a low of $5.30 and a high of $5.90, as of Nov 16, 2026.

Have analysts raised Healthequity's earnings estimates?

Healthequity's FY27 EPS consensus held at $4.72 over 90 days, as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.